Sunday, December 07, 2014 11:07:57 AM
Update on GSO targets 05/15 (just a strategic view of IDRA)
IMO 9200 trials partnership deals 08/15 (hoping to see !)
Full data for WM 09/15 (partial data this week!)
GSO kick-offs, clinical trials 10/15 (should add a few bucks!)
Rare diseases Duchenne Dermatomyositis clinical updates 04/16
DLBCL full data 05/16
New indications on rare diseases 06/16
FDA break through application for WM and DLBCL 08/16
Accelerated approvals followed by sales on both WM and DLBCL 03/17
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM